Malaysia is one of the top medical tourism and medical research destinations in the world, particularly for early phase clinical trials. It has comprehensive regulations and guidelines that seek to enforce safe product development, safeguard patients, and encourage research. Malaysia has also continued to evolve towards an integrated regulatory environment, covering key aspects of stem cell, and cell and gene therapy development (i.e., regulation of products, medical practices and facilities). Additionally, Malaysia also developing national policies and professional guidelines on cell and gene therapy. Like many countries, Malaysia is also seeking to combat unproven treatments. Tune in to this open access webinar to hear some of Malaysia's local distinguished pioneers and key experts, discussing stem cells and cell and gene therapy research, as well as development, application, manufacturing, regulation, and law and ethics as we shine a light on this fascinating and highly innovative country.
#eventfeed